Garri Chilingaryan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Monoclonal Antibody

Top Venues

Pathogens (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Armine Hovakimyan, Garri Chilingaryan, Olga King, Joia Kai Capocchi, Jean Paul Chadarevian, Hayk Davtyan, Roman Kniazev, Michael G Agadjanyan, Anahit Ghochikyan
mRNA Vaccine for Alzheimer's Disease: Pilot Study. Vaccines 12 (6) (2024)
Tatevik Antonyan, Garri Chilingaryan, Karen Zagorski, Manush Ghazaryan, Armine Hovakimyan, Hayk Davtyan, Irina Petrushina, Olga King, Roman Kniazev, Nikolai Petrovsky, Anahit Ghochikyan
MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity. Pathogens (Basel, Switzerland) 13 (6) (2024)
Tatevik Antonyan, Garri Chilingaryan, Karen Zagorski, Manush Ghazaryan, Armine Hovakimyan, Hayk Davtyan, Irina Petrushina, Olga King, Roman Kniazev, Nikolai Petrovsky, Anahit Ghochikyan
MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity. Pathogens (Basel, Switzerland) 13 (6) (2024)
Armine Hovakimyan, Garri Chilingaryan, Olga King, Joia Kai Capocchi, Jean Paul Chadarevian, Hayk Davtyan, Roman Kniazev, Michael G Agadjanyan, Anahit Ghochikyan
mRNA Vaccine for Alzheimer's Disease: Pilot Study. Vaccines 12 (6) (2024)
Tatevik Antonyan, Garri Chilingaryan, Karen Zagorski, Manush Ghazaryan, Armine Hovakimyan, Hayk Davtyan, Irina Petrushina, Olga King, Roman Kniazev, Nikolai Petrovsky, Anahit Ghochikyan
MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity. Pathogens (Basel, Switzerland) 13 (6) (2024)
Armine Hovakimyan, Garri Chilingaryan, Olga King, Joia Kai Capocchi, Jean Paul Chadarevian, Hayk Davtyan, Roman Kniazev, Michael G Agadjanyan, Anahit Ghochikyan
mRNA Vaccine for Alzheimer's Disease: Pilot Study. Vaccines 12 (6) (2024)
Mohammad M Al-Sanea, Garri Chilingaryan, Narek Abelyan, Michael Mamikonyan, Hayk Gasparyan, Sargis Hovhannisyan, Abdelrahman Hamdi, Ahmed R Ali, Samy Selim, Ahmed A B Mohamed
Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors. PloS one 17 (9) (2022)
Mohammad M Al-Sanea, Garri Chilingaryan, Narek Abelyan, Arsen Sargsyan, Sargis Hovhannisyan, Hayk Gasparyan, Smbat Gevorgyan, Sarah M Albogami, Mohammed M Ghoneim, Ahmed K Farag, Ahmed A B Mohamed, Ashraf K El-Damasy
Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery. Life (Basel, Switzerland) 11 (10) (2021)
Mohammad M Al-Sanea, Ahmad J Obaidullah, Mohamed E Shaker, Garri Chilingaryan, A F M Motiur Rahman, Nawaf A Alsaif, Hamad M Al Kahtani, Sultan A Alsubaie, Mohamed A Abdelgawad
A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights. Molecules (Basel, Switzerland) 26 (2) (2021)
Nourhan Hisham Shady, Alaa M Hayallah, Mamdouh F A Mohamed, Mohammed M Ghoneim, Garri Chilingaryan, Mohammad M Al-Sanea, Mostafa A Fouad, Mohamed Salah Kamel, Usama Ramadan Abdelmohsen
Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study. Molecules (Basel, Switzerland) 26 (12) (2021)
Mohammed S Abdel-Maksoud, Ahmed A B Mohamed, Rasha M Hassan, Mohamed Abdelwahab Abdelgawad, Garri Chilingaryan, Samy Selim, Mohamed S Abdel-Bakky, Mohammad M Al-Sanea
Design, Synthesis and Anticancer Profile of New 4-(1H-benzo[d]imidazol-1-yl)pyrimidin-2-amine-Linked Sulfonamide Derivatives with V600EBRAF Inhibitory Effect. International journal of molecular sciences 22 (19) (2021)